Nurix Therapeutics, Inc. (NRIX)
15.49
-0.15
(-0.96%)
USD |
NASDAQ |
Feb 18, 16:00
15.75
+0.26
(+1.68%)
After-Hours: 19:22
Nurix Therapeutics Total Liabilities (Quarterly) : 163.82M for Nov. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Incyte Corp. | 1.803B |
| Madrigal Pharmaceuticals, Inc. | 736.72M |
| SELLAS Life Sciences Group, Inc. | 5.925M |
| Arcturus Therapeutics Holdings, Inc. | 57.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 702.56M |
| Shareholders Equity (Quarterly) | 538.75M |
| Debt to Equity Ratio | 0.1034 |
| Current Ratio | 7.018 |
| Net Debt Paydown Yield | -0.32% |